Boston Scientific Corp (WBO:BSXC)
€ 86 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 70/100

Boston Scientific Corp at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 04:15PM GMT
Release Date Price: €41.85 (-2.38%)
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Welcome. I'm Robbie Marcus, the med tech analyst at JPMorgan. Really excited to have our next session, Boston Scientific. Going to introduce the CEO, Mike Mahoney, to come up and do a presentation, and then we'll turn to Q&A. Mike?

Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO

Good morning, everyone. Hey, Robbie. JPMorgan, Wednesday, you're hanging in there? First of all, it's such an honor for me to help lead Boston Scientific. I've been with the company for 10 years now, and it's just real -- an honor and a pleasure to work with the team.

I appreciate the shareholders that are in attendance. And hopefully, we're going to give you a quick summary of the company in about 20 minutes here, and you'll find the company as exciting as I do. Here are our safe harbors, our regulatory disclaimers and our financial disclaimers.

When it comes to the company that -- you have so many health care companies talking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot